Cresilon

Cresilon

Share

Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com.

--
DISCLAIMER: The products and the claims made about specific products on or through this site have not been evaluated by the United States Food and Drug

06/02/2026

“I am alive, and it saved me from losing my hand.” - Casey Bolin, Patient

Real-world feedback on TRAUMAGEL® from the field.

Learn more at traumagel.com

05/25/2026

This Memorial Day, we remember and honor the heroes who served our nation.

05/14/2026

We’re at the FDNY SRFM 2026 Symposium. Stop by to learn more about TRAUMAGEL®.

04/29/2026

Evacuation timelines can extend significantly in large-scale conflict zones, requiring prolonged field care.

Learn more about TRAUMAGEL® at Booth 514, SOMA 2026.
1. Eastridge BJ et al. Death on the battlefield (2001–2011): implications for combat casualty care. J Trauma Acute Care Surg. 2012;73(6 Suppl 5):S431–7. doi:10.1097/TA.0b013e3182755dcc

04/29/2026

Uncontrolled hemorrhage remains the leading cause of preventable death in combat. When seconds matter, rapid bleeding control can make the difference.

Stop by Booth 514 at SOMA 2026 to learn more about TRAUMAGEL®

1. Russ S. Kotwal et al., Eastridge BJ et al. Died of wounds on the battlefield: causation and implications for improving combat casualty care. J Trauma. 2011;71(1 Suppl):S4–8. doi:10.1097/TA.0b013e318221147b

04/28/2026

NEWS: TRAUMAGEL® Published in JSOM (Journal of Special Operations Medicine)

The Use of Traumagel for Hemorrhage Control and Tourniquet Removal: A Case Series of Traumatic Extremity Injuries

A recent peer-reviewed publication highlights how TRAUMAGEL can support hemorrhage control in tactical and prolonged field care environments.

Key findings from operational use cases in traumatic hemorrhage:

- Demonstrated rapid hemorrhage control in extremity injuries
- Enabled tourniquet conversion and removal without rebleeding
- Conformed to irregular wound geometries where traditional methods are limited
- Supported durable hemostasis when used alongside standard interventions
- Showed potential to reduce risks associated with prolonged tourniquet use

These findings reinforce TRAUMAGEL’s potential as an adjunct solution in tactical casualty care, where rapid, reliable bleeding control is critical for both patient outcomes and mission success.

Read the full article in JSOM: https://pubmed.ncbi.nlm.nih.gov/42034451/

Authors: Cassidy Wheeler, Patrick Greiffenstein, Jennifer Brewer, Tyler Nicholas Carruth, Easton Stelly, Christopher McCuller

04/28/2026

TRAUMAGEL® is proud to announce that we will be presenting at SOMA 2026, where our work will be featured as a podium presentation presented by Lieutenant Paramedic David Kleiman.

To learn more about TRAUMAGEL® stop by Booth 514.

Learn more at https://cresilon.com/2026/04/27/cresilon-announces-traumagel-presentations-at-the-2026-special-operations-medical-association-scientific-assembly/

04/27/2026

TRAUMAGEL® is honored to be presenting at SOMA 2026, with our work selected as a poster presentation.

Join us for “Prehospital Emergency Response in a Partial Hand Amputation with Ulnar Artery Transection: A Case Report,” presented by EMS Training Captain Jeff Elian. To learn more about TRAUMAGEL® stop by Booth 514

Learn more at https://cresilon.com/2026/04/27/cresilon-announces-traumagel-presentations-at-the-2026-special-operations-medical-association-scientific-assembly/

Want your business to be the top-listed Business in Brooklyn?
Click here to claim your Sponsored Listing.

Category

Telephone

Address


122 18th Street
Brooklyn, NY
11215